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Objective: Although the association between vulnerable lesions and cardiovascular events is well established, little is
known about their relationship to postsurgery restenosis. To address this issue, we initiated a prospective, nonrandom-
ized study to examine the femoral plaques on both sides in patients who were undergoing eversion carotid endarterectomy
(CEA) and were longitudinally followed-up for early restenosis development.
Methods: The final analysis enrolled 321 patients (189 women) with a median age of 67.0 years (interquartile range,
59.0-73.0 years), who underwent eversion CEA (2005 to 2007). Using duplex ultrasound scanning, we evaluated 321
common femoral atherosclerotic lesions on the day before CEA. A quantitative scale was used to grade the size of plaques
as grade 1, one or more small plaques (<20 mm2); grade 2, moderate to large plaques; and grade 3, plaques giving flow
disturbances. The plaque morphology in terms of echogenicity was graded as echolucent, 1; predominantly echolucent,
2; predominantly echogenic, 3; echogenic 4; or calcified, 5. The plaque surface was categorized as smooth, irregular, or
ulcerated. The patients underwent carotid duplex ultrasound imaging at 6 weeks and at 6, 12, and 24 months after CEA.
Mann-Whitney U test, 2 test, and multivariate logistic regression were used for statistical evaluation.
Results: Internal carotid artery restenosis of >50% was detected in 33 patients (10.28%) in the operated region. Neither
the size (grade 1, P  .793; grade 2, P  .540; grade 3, P  .395) nor the surface characteristics of the femoral plaques
(smooth, P  .278; irregular, P  .281; ulcerated, P  .934) were significantly different between the patients with and
without carotid restenosis. Echolucent-predominantly echolucent femoral lesions were an independent predictor of
recurrent carotid stenosis (adjusted odds ratio, 5.63; 95% confidence interval, 2.14-10.89; P < .001).
Conclusion: Ultrasound evaluation of femoral plaque morphology before CEA can be useful for identifying patients at
higher risk for carotid restenosis. ( J Vasc Surg 2010;51:345-50.)Eversion endarterectomy of the carotid artery (CEA) is
a generally accepted elective surgical method in both symp-
tomatic and asymptomatic patients with significant internal
carotid artery (ICA) stenosis. Despite of the best surgical
care, recurrent stenosis has been reported to occur in 1% to
36% of patients.1 Stoney and String2 were the first to
classify carotid restenoses into two distinct types: lesions
occurring 2 years after CEA were attributed to intimal
hyperplasia and thereafter, to recurrent atherosclerosis.
Multiple inflammatory mediators, including growth
factors and cytokines, have been postulated to play different
roles to trigger the neointimal response.3 Similarly, inflam-
mation is involved in all stages of the atherosclerotic pro-
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doi:10.1016/j.jvs.2009.08.080cess, from the initiation of the fatty streak to the final stage
of plaque rupture.4 Histologic findings have revealed that
high-risk vulnerable lesions have a thin fibrous cap, a large
lipid pool, and a macrophage dense inflammation on or
beneath their surface.5,6 Ultrasound (US) images show
these rupture-prone plaques are predominantly echolucent
and heterogeneous, as well as ulcerated.7
Previous work has shown that the presence of femoral ath-
erosclerotic lesions has a predictive value for future cardiovascular
events. Moreover, the size and echogenicity of the plaques were
important determinants of the vascular risk.8 Novo et al9 re-
ported a significantly higher prevalence of femoral lesions in
patients with restenosis after percutaneous coronary interven-
tions than in those without recurrent lumen narrowing. A 2009
study by Sirico et al10 demonstrated that in patients with periph-
eral artery disease, the presence of echolucent femoral plaques
was associated with a greater prevalence of echolucent carotid
lesions.Much less is known about the femoral plaques in relation
to recurrent carotid stenosis. The primary aim of the present
study was to investigate the putative role of femoral plaque size
and lesion characteristics on US imaging in patients who were
undergoing carotid eversion endarterectomy and were longitu-
dinally followed-up for early ICA restenosis development.
PATIENTS AND METHODS
This prospective study enrolled 402 consecutive pa-tients scheduled for CEA between June 1, 2005, and
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vascular Surgery Department of Semmelweis University,
Budapest, Hungary. None of these patients had prior ipsi-
lateral CEA or stent implantation. The study was per-
formed in accordance with the Declaration of Helsinki and
was approved by the local Ethics Committee. All partici-
pants provided informed consent.
Patient data. At baseline, clinical history and physical
examination were evaluated with special attention to car-
diovascular risk factors to determine their relationship with
occurrence of carotid restenosis: age, gender, body mass
index (BMI), history of smoking, and presence of hyper-
tension, diabetes mellitus, and hyperlipidemia. The risk
factors were assessed by a review of medical records com-
bined with a patient questionnaire.
● The BMI was calculated as kg/m2.
● Smoking habit was coded as smokers and nonsmokers.
Current cigarette smoking was defined as a daily intake
of more than five cigarettes. Nonsmokers included
those who had never smoked, former smokers who had
quit smoking for 1 year before the study, and those
whose daily intake was less than five cigarettes.
● Hypertension was diagnosed in patients with resting
blood pressure values 140/90 mm Hg measured
repetitively (at least twice) and was assumed to be
present in patients taking antihypertensive drugs.
● Diabetes was defined as self-reported history of diabe-
tes mellitus, use of antidiabetic drugs, or a fasting
blood glucose 5.8 mmol/L, oral glucose tolerance
test results suggestive of disease, or glycated hemoglo-
bin A1C level 6.2%.
● Hyperlipidemiawas defined as any or all of an elevationof
fasting triglycerides 1.7 mmol/L, total cholesterol
5.0 mmol/L, or low-density lipoprotein cholesterol
3.0 mmol/L, and was considered to be present in
patients receiving lipid-lowering medication.
Neurologic events were also documented and catego-
rized as transient ischemic attack (TIA), minor stroke, and
major stroke. A TIA was termed any neurologic deficit that
resolved 24 hours without evidence of any residual neu-
rologic damage thereafter. A minor stroke was classified as
a new neurologic event that resulted in a slight impairment
of neurologic function that either resolved completely 7
days or caused an increase in the National Institute of
Health Stroke Scale (NIHSS) of 4. A new neurologic
deficit that persisted 7 days or increased the NIHSS by
4 was defined as a major stroke.11 Current use of statin
and antiplatelet (acetylsalicylic acid, dipyridamole, clopi-
dogrel) therapy was recorded for each patient.
Baseline US evaluation. Each patient had femoral US
examination the day before surgery at our department.
B-mode and color Doppler measurements were performed
using a SSA-700A US machine (Aplio; Toshiba Medical
Systems, Tustin, Calif) equipped with a linear array broad-
band 7-4-MHz transducer. All femoral duplex US (DUS)
scans were performed and analyzed by the same senior
vascular radiologist. The common femoral artery (CFA)was scanned bilaterally distal to the inguinal ligament along
a section approximately 4 cm proximal and 1 cm distal to
the flow divider (the site where the artery divides into the
superficial and profound femoral arteries) to assess the
occurrence of plaques.
Femoral plaque was defined as a focal widening 50%
relative to the adjacent segment, as recommended by the
US Task Force on noninvasive atherosclerosis measure-
ment.12 Each plaque was measured in its own longitudinal
view in which the plaque was biggest. A cursor on the
screen was used to trace the perimeter of the plaque, and
intrinsic software of the DUS scanner was used to compute
the cross-sectional area of the plaque. The cross-sectional
areas of all CFA plaques were then summed to give the total
plaque area. The plaques were categorized as grade 1, one
or more small plaques (total plaque area20 mm2); grade
2, moderate to large plaques; and grade 3, plaques causing
flow disturbances.13 This analysis included plaques in the
near wall as well as the far wall of the vessel. When the
plaque size was different between the two sides, the higher
grade was considered for further evaluation.
The plaque morphology in terms of echogenicity was
visually judged and graded from 1 to 5 as echolucent, 1;
predominantly echolucent, 2; predominantly echogenic, 3;
echogenic, 4; or calcified, 5.14 Echogenicity was standard-
ized against three reference structures: flowing blood for
echolucent, iliopsoas muscle for isoechogenic, and the
bright far wall media-adventitia interface for echogenic
plaques.15 Calcified plaques had zones of acoustic shadow-
ing that obscured the deeper part of the arterial wall as well
as the vessel lumen. The plaque surface was categorized as
smooth, irregular, or ulcerated. The height variations of the
surface were determined by using the software incorpo-
rated in the US machine. The surface was regarded as
irregular in the case of height variations of between 0.4 and
2 mm on the contour of the plaque.
Ulceration was defined as a recess that was at 2 mm
deep and 2mm long and had an area of reversed flowwithin
the recess or a zone of low flow signal at the level of the
recess.16 In patients withmultiple plaques, only the thickest
was selected for analysis.
The US images were sent to a PACS (Picture Archiving
Communication System) workstation, and 50 randomly
chosen plaques were re-evaluated by the same radiologist at
the end of the study. The intraobserver reproducibility for
plaque size and morphology (echogenicity, surface charac-
teristics) was good ( .81,  .79,  .71, respectively).
Eversion CEA. The criteria to perform CEA were
based on the recommendations by the American Heart
Association.17 The procedures were performed with the
patient under deep general anesthesia by four experienced
vascular surgeons. After systemic heparinization, the distal
internal, common, and external carotid arteries were
clamped. The ICA was transected obliquely from the com-
mon carotid artery (CCA). The ICA wall was everted over
the atheromatous core until a distal end point was directly
visualized. After the ICA had been completely endarterec-
tomized, significant disease in the common and external
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mosed to the CCA. All patients were prescribed an acetyl-
salicylic acid regimen (325 mg daily) 24 hours postoper-
atively, which was continued indefinitely.
Follow-up. Follow-up visits were scheduled at 6
weeks, and at 6, 12, and 24 months after CEA. Outpatient
carotid DUS scans were performed by another experienced
radiologist who was unaware of the results of CFA plaque
characterization. The common, internal, and external ca-
rotid arteries on both sides were examined in the standard
fashion. Representative values of peak systolic velocity
(PSV) and end-diastolic velocity (EDV) were measured.
The PSV of the ICA was the primary parameter for the
grading of ICA restenosis. If the degree of recurrent ICA
stenosis was indeterminate according to the PSVs, then
additional parameters, including the ICA/CCA PSV ratio
and the ICA EDV were considered. A 50% to 69% ICA
restenosis was diagnosed when ICA PSV was 125 to 230
cm/s. Additional criteria included an ICA/CCA PSV ratio
of 2.0 to 4.0 and ICA EDV of 40 to 100 cm/s. A 70%
ICA restenosis was diagnosed when the ICA PSV was
230 cm/s. Additional criteria included an ICA/CCA
PSV ratio 4.0 and ICA EDV 100 cm/s. These criteria
had been established according to the Society of Radiolo-
gists in Ultrasound Consensus Conference and were inter-
nally verified.18
Statistical analysis. Statistical analyses were per-
formed using Statistica 8.0 software (StatSoft Inc, Tulsa,
Okla). Categoric variables were expressed as numbers and
percentages and were compared between groups using the
2 test. Continuous variables were assessed for normality by
using the Shapiro-Wilk test. Because continuous variables
exhibited a non-Gaussian distribution, they were expressed
as medians and interquartile ranges (IQR) and were com-
pared using the nonparametric Mann-Whitney U test. All
analyses were two-tailed and values of P  .05 were con-
sidered as statistically significant.
To identify the independent predictors of early carotid
restenosis, multivariate logistic regression was done with
adjustment for age, gender, BMI, and follow-up time. The
dependent variable was 50% ICA restenosis. In case of
combined variables, patients who fulfilled the criteria of
both single variables were compared with those who did
not have the combined characteristics. All variables with a
value of P  .05 in the univariate analysis were tested.
Intraobserver reproducibility was calculated using the Co-
hen  statistic.
RESULTS
Nine of the 402 patients (2.24%) did not undergo
follow-up because of all-causemortality, including stroke in
three patients, acute myocardial infarction in four, and
cancer in two. No plaques were found in the CFAs in 18
patients (4.48%) and they were excluded from the study
because the inclusion criterion for this investigation was the
presence of femoral plaque. Unilateral or bilateral femoral
artery reconstruction was done in 13 patients (3.23%).
Patients with unilateral femoral artery reconstruction werealso excluded under the assumption that the revascularized
artery had the higher plaque grade. The evaluation of the
CFA lesions was impossible because of the marked acoustic
shadow in 15 patients (3.73%). Bilateral femoral occlusive
disease was present in eight patients (1.99%). Four patients
(0.99%) were followed-up at other hospitals, and 14
(3.48%) were lost to follow-up.
The final analysis therefore included 321 patients (189
women) with 321 arteries. Their median age was 67.0 years
(IQR, 59.0-73.0 years). Their median BMI was 25.0
kg/m2 (IQR, 21.0-26.0 kg/m2). Risk factors included
smoking in 258 patients (80.37%), hypertension in 197
(61.37%), diabetes mellitus in 78 (24.30%), and hyperlipid-
emia in 127 (39.56%). Preoperatively, 95 patients (29.60%)
were asymptomatic, 194 (60.44%) had TIA, 26 (8.10%)
had minor stroke, and 6 (1.87%) had major stroke. Statin
usage in 135 patients (42.06%) and antiplatelet therapy in
220 patients (68.54%) was recorded.
Follow-up period. The median follow-up time was
24.3 months (IQR, 22.9-25.4 months). Five (3 minor
strokes, 2 major strokes) nonfatal perioperative strokes
(1.56%) occurred. Cardiogenic embolization caused minor
strokes in two additional patients 2 years after CEA.
Nonfatal acute myocardial infarction was recorded in five
patients (1.56%).
All patients underwent US examinations preoperatively
and at 24 months. The cutoff point for the definition of
residual stenosis was 5.79 weeks (IQR, 4.86-6.95 weeks).
Residual lesions (50%) were found in 12 patients (3.74%),
but they remained stable during the rest of the follow-up.
ICA restenosis of 50% was detected in 33 patients
(10.28%), among them 17 (5.30%) had severe recurrent
stenosis (70%) in the operated region. Restenosis was
detected at 6.13 months (IQR, 5.60-6.67 months) after
CEA in eight patients, at 12.00months (IQR, 11.42-12.65
months) in 19 patients, and in six patients thereafter (Fig).
Eleven patients with significant recurrent lumen narrowing
were assigned for carotid stenting, the other patients con-
tinued to receive medical treatment.
Baseline characteristics of the patients with and
without carotid restenosis. Hyperlipidemia was more
common in patients with recurrent carotid stenosis (P 
.001). In case of preoperative symptoms (TIA, stroke) the
statistical analysis did not reveal a significant difference
between patients with (P  .723) and without (P  .859)
carotid restenosis. No significant difference was found in
statin treatment between the groups of patients with and
without restenosis, as well as for antiplatelet usage (P 
.964, P  .584, respectively; Table I).
Presurgical femoral plaque size in patients with and
without recurrent carotid lumen narrowing. Plaques in
the CFA were grade 1 in 91 patients (28.35%), grade 2 in
111 patients (34.58%), and grade 3 in 119 patients
(37.07%). The femoral plaque size did not differ signifi-
cantly between the groups (grade 1, P .793; grade 2, P
.540; and grade 3, P  .395, respectively; Table II).
Echogenicity and surface characteristics of the fem-
oral plaques before surgery in patients with and with-
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echolucent CFA plaques was significantly higher in patients
with documented restenosis during the follow-up period
Fig. Kaplan-Meier curve shows the incidence of restenosis after
eversion carotid endarterectomy.




P(n  33) (n  288)
Age, median (IQR), y 67 (58-73) 67 (60-73) .883
Female gender, No. (%) 18 (54.55) 171 (59.38) .593
BMI, median (IQR), kg/m2 24 (21-25) 25 (21-26) .200
Smoking, No. (%) 25 (75.76) 233 (80.90) .481
Hypertension, No. (%) 19 (57.58) 178 (61.81) .636
Diabetes mellitus, No. (%) 7 (21.21) 71 (24.65) .662
Hyperlipidemia, No. (%) 25 (75.76) 102 (35.42) .001a
Pre-op TIA, No. (%) 19 (57.58) 175 (60.76) .723
Pre-op stroke, No. (%) 3 (9.09) 29 (10.07) .859
Statin use, No. (%) 14 (42.42) 121 (42.01) .964
Antiplatelet use, No. (%) 24 (72.73) 196 (68.06) .584
BMI, Body mass index; IQR, interquartile range; TIA, transient ischemic
attack.
aStatistically significant.
Table II. Presurgical femoral plaque size in patients with
and without recurrent carotid lumen narrowing
Plaque size
Restenosis No restenosis
P(n  33) (n  288)
Grade 1, No. (%) 10 (30.30) 81 (28.13) .793
Grade 2, No. (%) 13 (39.39) 98 (34.03) .540
Grade 3, No. (%) 10 (30.30) 109 (37.85) .395(P .001). There were no significant differences in surfacecharacteristics of the femoral lesions between the patients
with and without recurrent lumen narrowing (smooth, P
.278; irregular, P .281; ulcerated, P .934, respectively;
Table III).
Predictors of early restenosis after eversion CEA.
The univariate analysis showed that hyperlipidemia was the
only cardiovascular risk factor associated with an increased
incidence of ICA restenosis during the follow-up (odds
ratio [OR], 3.24; 95% confidence interval [CI], 1.72-6.11;
P  .001). In this analysis, patients with echolucent or
predominantly echolucent CFA lesions were merged into
one group, and those with echogenic or predominantly
echogenic or calcified plaques formed another group. We
also merged patients with irregular or ulcerated plaque
surface into one group. The reason for this regrouping was
that only a few plaques were classified as echolucent, calci-
fied, or ulcerated. Patients with echolucent-predominantly
echolucent femoral plaques had a higher risk of ICA reste-
nosis compared with those with echogenic-predominantly
echogenic or calcified CFA lesions (OR, 4.99; 95% CI,
2.12-9.69; P  .001). Irregular femoral plaques only in
combination with echolucency were predictors of early
carotid restenosis development (OR, 3.09; 95% CI, 2.13-
7.05; P .034). None of the other US features of the CFA
plaques showed a relationship with recurrent ICA lumen
narrowing (Table IV). The multivariate logistic regression
analysis tested all variables with a value of P  .05 in the
univariate analysis, and all parameters remained statistically
significant in the multivariate logistic regression model
(Table V).
DISCUSSION
DUS imaging is a reliable and noninvasive method of
assessing the atherosclerotic plaque morphology and deter-
mining the degree of stenosis. Computer-assisted off-line
classification of the plaque echogenicity is an objective
technology with excellent reproducibility.16 However,
these measurements require separate equipment and are
time-consuming; therefore, it is difficult to apply them in
Table III. Echogenicity and surface characteristics of the




P(n  33) (n  288)
Echogenicity, No. (%)
Echolucent 1 (3.03) 9 (3.13) .976
Predominantly echolucent 12 (36.36) 41 (14.24) .001a
Predominantly echogenic 9 (27.27) 102 (35.42) .352
Echogenic 10 (30.30) 108 (37.50) .417
Calcified 1 (3.03) 28 (9.72) .204
Surface, No. (%)
Smooth 19 (57.58) 193 (67.01) .278
Irregular 13 (39.39) 87 (30.21) .281
Ulcerated 1 (3.03) 8 (2.78) .934
aStatistically significant.everyday clinical practice. In our study the plaque structure
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to be subjective, was found to be a valuable method for
plaque characterization.19
This study included one of the largest series of patients
in whom the femoral plaque size and lesion morphology
were evaluated. Patients with early carotid restenosis had a
significantly higher incidence of predominantly echolucent
femoral plaques than those without recurrent lumen nar-
rowing. Moreover, the plaque echogenicity seemed to be
superior to the surface characteristics of the atherosclerotic
lesions in regard to restenosis development, because irreg-
ular femoral lesions only in combination with echolucency
were independent predictors of early ICA restenosis devel-
opment. Vulnerable lesions were reported to develop si-
multaneously at multiple sites of the vascular bed.20 In
addition, trials with lipid-lowering or anti-inflammatory
therapy demonstrated a reduced rate of ischemic vascular
Table IV. Univariate analysis of predictors of early




OR (95% CI) P
Age 70 years 2.41 (0.72 to 8.43) .145
Female gender 1.59 (0.71 to 3.18) .317
Body mass index 25 kg/m2 1.61 (0.95 to 2.72) .921
Smoking 1.96 (1.79 to 2.50) .552
Hypertension 1.01 (0.95 to 1.09) .344
Diabetes mellitus 0.91 (0.37 to 2.41) .873
Hyperlipidemia 3.24 (1.72 to 6.11) .001a
Preoperative TIA, stroke 1.39 (0.49 to 3.65) .501
Preoperative statin use –2.24 (–12.97 to 8.81) .773
Preoperative antiplatelet use 3.01 (–3.72 to 9.06) .385
CFA plaque characteristics
Grade 3 3.01 (–1.59 to 7.89) .234
Irregular-ulcerated surface 1.92 (0.83 to 4.22) .109
Echolucent-predominantly
echolucent 4.99 (2.12 to 9.69) .001a
Grade 3 CFA plaque 2.72 (0.88 to 8.34) .113
Irregular-ulcerated 3.09 (2.13 to 7.05) .034a
CFA, common femoral artery;CI, confidence interval;OR, odds ratio; TIA,
transient ischemic attack.
aStatistically significant.
Table V. Multivariate analysis of predictors of early





OR (95% CI) P
Hyperlipidemia 3.37 (1.77-6.42) .001a
Echolucent-predominantly
echolucent CFA plaque 5.63 (2.14-10.89) .001a
Irregular-ulcerated 2.42 (1.17-6.03) .029a
CFA, Common femoral artery; CI, confidence interval; OR, odds ratio.
aStatistically significant.events and death, which can scarcely be conceived as asingle-plaque phenomenon.4,21 Thus, echolucent femoral
lesions may represent a vulnerable patient.
Because an inflammation phenomenon seems to be the
key component in both the development of unstable
plaques and in the formation of neointima,3,4 it may be
hypothesized that those systemic inflammatory factors that
are involved in the destabilization of atherosclerotic lesions
at the same time facilitate the restenotic process. An obser-
vation of Liapis et al22 that the presence of ipsilateral
echolucent carotid plaques before surgery is a predictor of
restenosis after CEA is in line with our findings. This
relationship was thought to be mediated by the remainders
of plaques at the CEA site. In a 2008 study, Kitta et al23
showed a strong association between the presence of
echolucent carotid lesions and in-stent restenosis after per-
cutaneous coronary interventions. However, it should be
taken into account that the pathogenesis of recurrent ste-
nosis after endarterectomy differs from the in-stent rest-
enotic process in many ways.
Schmidt et al8 revealed a positive correlation between
femoral plaque size and future cardiovascular events in middle-
aged men. The association remained present, albeit attenu-
ated, after adjustment for traditional cardiovascular risk
factors, including low-density lipoprotein cholesterol and
triglyceride levels, systolic blood pressure, and smoking.
We could not find a significant correlation between baseline
femoral plaque size and recurrent lumen narrowing after
CEA. The morphology of coexisting lesions rather than
size appears to be important in the development of reste-
nosis.
Previous studies support the notion that inflammation
is related not only to lesion structure but also to plaque
size.24,25 According to our observations, we assume, that
plaque size, “the amount of atherosclerosis” and echogenicity
are influenced by different systemic or local inflammatory
factors, or both, and those that are associated with plaque
morphology may also be involved in the restenotic process.
Several reports have examined the influence of systemic
factors such as age, gender, BMI, smoking, hypertension,
diabetes mellitus, and hyperlipidemia on the development
of recurrent stenosis after CEA, but none has succeeded in
establishing a globally accepted status.26,27 Our study iden-
tified patients with hyperlipidemia as being at particular risk
of developing restenosis. In hyperlipidemia, the rate of
LDL entry into the intima increases and the LDL under-
goes progressive oxidative modification in the subendothe-
lial space. The aggregation of oxidized LDL induces the
release of mitogens from platelets, macrophages, and endo-
thelial cells, which stimulate smooth muscle cell prolifera-
tion and may lead to neointima formation.28
Despite of the results of immunohistochemical and
biochemical studies that confirmed the role of oxidized
LDL in the restenotic process,29 the salutary effect of
lipid-lowering agents on the incidence of restenosis is con-
troversial. Some investigators have found a statistically sig-
nificant correlation, while others have not.27,30 Of note in
our study, the diagnosis of hyperlipidemia was determined
by an evaluation of available medical records of the patients.
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optimal control of their associated risk factors or were
treated with statins independently of their serum lipopro-
tein levels; therefore, definite conclusions about the impor-
tance of traditional risk factors on the development of early
recurrent lumen narrowing after surgery cannot be drawn
from our investigation.
CONCLUSIONS
Patients with echolucent-predominantly echolucent fem-
oral plaques, independently of their size, have an increased risk
for recurrent ICA stenosis development compared with those
with echogenic-predominantly echogenic or calcified athero-
sclerotic lesions.However, an important question thatmay be
asked is: If it is possible for us to examine the morphology of
the carotid plaques before CEA, do we have to care about the
composition of femoral lesions in regard to carotid restenosis?
The answer should be yes, but further prospective trials with
analysis of both carotid and femoral lesions in the same indi-
viduals are needed to reveal whether all patients or only
subgroups of patients would benefit from the evaluation of
CFA lesions before carotid surgery.
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